Sumary of India to push for patent waiver for COVID-19 vaccines at WTO:
- (Image Source: Shutterstock) India will lead demands for an intellectual property rights waiver for COVID-19 vaccines and supplies at a World Trade Organization (WTO) meeting next week, two government officials said.
- A year after India and South Africa introduced a proposal to temporarily waive intellectual property rights on COVID-19 vaccines and therapies at the WTO, negotiations are deadlocked in the face of opposition from some developed countries.
- Shyamal Misra, a senior official at the Ministry of Commerce, said India would not just be speaking for itself at the WTO ministerial conference in Geneva starting on Nov.
- Switzerland’s ambassador to the WTO Didier Chambovey said on Thursday the country was open to compromise but remained opposed to a full waiver.
- WTO members at a meeting of the Council for Trade-Related Aspects of Intellectual Property Rights (TRIPS) last week, agreed to continue negotiations until the start of the ministerial conference to seek a solution.
- Another senior government official, who is accompanying commerce minister Piyush Goyal at the meeting, told Reuters on Friday that India would push for a fair and equitable deal.